Antimicrobial stewardship emphasizes the timely transition from intravenous to oral antibiotic therapy to reduce the risk of catheter-associated infections and shorten hospital stays. However, the overuse of intravenous antibiotics remains a significant issue in China. Understanding the factors that influence patients' willingness to accept intravenous-to-oral switch (IVOS) therapy from their perspective is essential. This study aims to explore inpatients' willingness to accept IVOS therapy and its potential influencing factors, based on the Health Belief Model (HBM), providing evidence for the development of more effective intervention strategies. Between June and July 2025, a qualitative study guided by the HBM was conducted at a tertiary hospital in China. Fifteen inpatients receiving antibiotic therapy from five wards with high rates of intravenous antibiotic use were purposively selected for semi-structured interviews. Data were thematically analyzed and reported in accordance with the COREQ guidelines. The study identified two themes and nine subthemes: (1) motivators to accept IVOS therapy (perceived benefits, high perceived severity, concerns about infusion safety, and action cues), (2) barriers to accept IVOS therapy (concerns about oral antibiotic effectiveness, low perceived susceptibility, low perceived severity, the "anti-inflammatory drug" label, and self-efficacy). This study indicates that patients lack sufficient awareness of the efficacy of oral antibiotics and the severity of antimicrobial resistance. Targeted interventions, particularly public education initiatives, can improve patient understanding of these issues, encourage more informed therapy decisions, and potentially increase acceptance of IVOS therapy.
Despite substantial evidence confirming that intravenous-to-oral switch (IVOS) of antibiotics is non-inferior to intravenous administration in terms of efficacy and safety for various infections, intravenous antibiotics remain widely used in China, with patient preferences potentially influencing treatment decisions. This study aims to explore the willingness of Chinese residents to accept IVOS therapy and identify the associated factors using the Health Belief Model (HBM). A cross-sectional survey was conducted in Guangxi Province, China, from October to November 2025. A self-designed structured questionnaire was used to collect information on participants' sociodemographic characteristics, antibiotic knowledge, and health beliefs. Structural equation modelling (SEM) was employed to analyze the factors influencing residents' intention to accept IVOS therapy. A total of 400 participants were included in the study. Overall, residents' knowledge of antibiotics was moderate, with an average correct response rate of 60% across 10 questions. Perceived benefits (β = 0.59, p < 0.001) and self-efficacy (β = 0.27, p < 0.001) were positively associated with the intention to accept IVOS therapy in this cross-sectional study. The HBM variables explained 56.4% of the variance in behavioral intention.
Antimicrobial Stewardship Pharmacy Consultation (ASPC) in China has been shown to reduce patients' length of stay (LOS). However, prolonged LOS remains a challenge, resulting in unnecessary psychological and financial burden for patients. This study aimed to develop a prediction model using ASPC parameters to identify high-risk pediatric patients with infectious diseases. These patients received ASPC interventions but still experienced prolonged LOS, which defined their high-risk status. Predictors for the ASPC model were selected using lasso regression, a nomogram was developed using multivariate logistic regression, and internal validation was performed using tenfold cross-validation. The data set consisted of 474 electronic medical records of pediatric patients with infectious diseases from two hospitals. LOS was dichotomized at the median, and patients with LOS greater than the median were considered to have achieved the outcome. The proportion of outcome events was set at 50% by design. Five independent predictors were identified in the ASPC model: (1) the suggestions from the crucial consultation (OR: 1.74; 95% CI: 1.10 to 2.74), (2) weight (OR: 0.98; 95% CI: 0.97 to 1.00), (3) whether the patient received first aid (OR: 0.54; 95% CI: 0.3 to 1.00), (4) the aim of the crucial consultation (OR: 0.15; 95% CI: 0.03 to 0.66), and (5) whether the patient was critically ill (OR: 0.22; 95% CI: 0.12 to 0.41). The ASPC model showed good discrimination with a C-statistic of 0.772 (95% CI: 0.748 to 0.797) and good calibration performance with intercept and slope values of 0.00 (95% CI: -0.12 to 0.12) and 0.93 (95% CI: 0.82 to 1.04), respectively, under tenfold cross-validation. The antimicrobial stewardship pharmacy consultation model has good discrimination and calibration, and effectively identifies patients at risk for prolonged length of stay. Extensive research on clinical pharmacy practice has highlighted the important role that clinical pharmacists play in patient care and their valuable contributions to personalized medical treatment. However, the quality of pharmacy consultations in China still requires improvement to gain wider recognition from clinicians. Our study examined the impact of Antimicrobial Stewardship Pharmacy Consultations (ASPCs) on the length of stay (LOS) among pediatric patients with infectious diseases and developed a risk prediction model to identify the high-risk patients who received ASPC interventions yet still experienced prolonged LOS. This model has the potential to enhance the quality of ASPC, reduce patients' psychological and financial burdens, and support the advancement of clinical pharmacy practice in China.